The Coronavirus disease (COVID-19) was declared a global pandemic by the WHO in March 2020. From then on, pharmaceutical companies were in constant search of a possible cure or how to mitigate the disease. By the late 2020s, several vaccine maker companies started applying for COVID-19 vaccines Emergency Use Authorization (EUA) in the country. EUA is the authorization given to a medicine or vaccine during a public health emergency.
Vaccines reduce risks of getting a disease by working with your body’s natural defense to build protection (WHO). Several vaccine platforms are available in the country:
• mRNA vaccines
• viral vector vaccines
• inactivated vaccines
• protein subunit vaccines
In March 2021, COVID-19 vaccines started its rollout in the country. Reports of suspected adverse reactions are closely monitored from the start of the vaccination up until now.
Aside from COVID-19 vaccines, several medicines were also granted EUA starting the last quarter of 2021. Monitoring of adverse reactions to these medicines is also closely monitored.
For more information on EUA and COVID-19 vaccine reports, click here.
Last updated: 11 August 2022